In phase 2 clinical trials, 2% of patients reported pancreatitis with a 12 mg dose
The trend: Consumer use of weight loss drugs surged in 2025
BPC-157 for Diabetic and Chronic Wounds Diabetic wounds and other chronic wounds pose significant clinical challenges
The distinction affects metabolic rate, physical function, appearance, and long-term weight maintenance probability

Ajay Goyal, FACS Weight Loss Medications, GLP-1 Injections and GLP-1 Pill Comparison Medications Zepbound (GLP-1 Tirzepatide) (GLP-1 Tirzepatide) Wegovy (GLP-1 Semaglutide) (GLP-1 Semaglutide) Saxenda (Liraglutide) (Liraglutide) Wegovy Pill (GLP-1 Semaglutide) (GLP-1 Semaglutide) Foundayo (orforglipron) (orforglipron) Qsymia (Phentermine & Topiramate) (Phentermine & Topiramate) What to Expect One weekly injection One weekly injection One injection daily One tablet daily One tablet daily One tablet daily How it helps you lose weight Reduce appetite, food intake, body fat and body weight Increase satiety and control portions Increase satiety and control portions Increase satiety and control portions Slows digestion and reduces appetite Suppress appetite and control cravings Weight loss 16-20% of body weight 4 15-18% of body weight 5 15-18% of body weight 6 14-17% of body weight 11-12.4% of body weight 10% of body weight 7 *Our board-certified doctors prescribe FDA-approved prescription GLP-1 medications and injections to people in NJ who meet the clinical qualifications

The preclinical safety data is reassuring, with no significant adverse effects in animal studies at doses well above therapeutic ranges, but human long-term data does not exist